Desq Long
Sign in

Superseded. This filing was amended. The current version is 0000886982-26-000522. This page remains published as the record of what was originally filed.

SEC FORM 4
$2,211.00

Attovia Therapeutics, Inc. (ATTO)

Sale of 100 shares at $22.11 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 13, 2026FILED +8 DAYS

Source: SEC Form 4 · 0000886982-26-000495 · filed 2026-08-13 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Attovia Therapeutics, Inc. (ATTO)." Disclosed 2026-08-13. https://desqlong.com/cards/0000886982-26-000495-10 (retrieved 2026-09-26).